2025年2月21日, Gyre Therapeutics(GYRE)披露2笔公司内部人交易情况。董事Ma Songjiang于2025年2月20日卖出2000股。 Gyre Therapeutics, Inc.在特拉华州注册成立。该公司及其子公司是一家生物制药公司,该公司是一家生物制药公司,致力于研究、开发、制造和商业化治疗器官纤维化的创新药物。
This test flight route also marks the start of the construction of a low-altitude transportation network in the YRD region.
Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.1 billion market cap biotech company with a robust current ratio of 3.72, reported selling shares worth $48,029, according to a ...
The pagoda was built sometime between 1068 and 1077 during the Northern Song Dynasty. Many changes were made during repairs in the Ming and Qing dynasties, but the main structure and style ...
Get all travelers to sign your disclaimerA reader wonders: Can't we just post our disclaimer online like the major OTAs do? True or false: 'No turning back from DEI'The travel industry sent mixed ...